Company Description
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States.
The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line.
It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects.
The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups.
This segment serves health plans, commercial employers, labor groups, and state and local governments.
In addition, it offers its products through online retail site. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.
On October 15, 2023, Rite Aid Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of New Jersey.
| Country | United States |
| Founded | 1927 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Employees | 47,000 |
| CEO | Jeffrey Stein |
Contact Details
Address: 1200 Intrepid Avenue, Second Floor Philadelphia, Pennsylvania | |
| Website | riteaid.com |
Stock Details
| Ticker Symbol | RADCQ |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0000084129 |
| ISIN Number | US7677548726 |
| Employer ID | 23-1614034 |
| SIC Code | 5912 |
Key Executives
| Name | Position |
|---|---|
| Jessica Kazmaier | Executive Vice President, Chief Human Resources Officer and Chief of Staff to the Chief Executive Officer |
| Jeffrey Scott Stein | Chief Executive Officer and Chief Restructuring Officer |
| Matthew C. Schroeder | Chief Financial Officer and Executive Vice President |
| Steven K. Bixler | Chief Accounting Officer and Senior Vice President |
| Christine Rose | Senior Vice President and Chief Information Officer |
| Byron Purcell | Vice President of Investor Relations and Treasurer |
| Thomas J. Sabatino Jr. | Executive Vice President and Chief Legal Officer |
| Joy Errico Seusing | Senior Vice President and Chief Communications Officer |
| Jeanniey Walden | Senior Vice President and CMO |
| Karen Lesley Staniforth | Senior Vice President of Clinical Pharmacy Services and Chief Pharmacy Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 30, 2024 | T-3/A | Filing |
| Aug 29, 2024 | T-3/A | Filing |
| Aug 29, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 29, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 29, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 29, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 29, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 29, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 29, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 29, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |